These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32741827)

  • 1. Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer's Disease.
    González A; Guzmán-Martínez L; Maccioni RB
    J Alzheimers Dis; 2020; 77(2):877-883. PubMed ID: 32741827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population.
    Guzmán-Martínez L; Tapia JP; Farías GA; González A; Estrella M; Maccioni RB
    J Alzheimers Dis; 2019; 67(4):1181-1186. PubMed ID: 30775977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelets tau: a potential peripheral marker for Alzheimer's disease.
    Neumann K; Farías G; Slachevsky A; Perez P; Maccioni RB
    J Alzheimers Dis; 2011; 25(1):103-9. PubMed ID: 21368381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monoclonal antibody, Alz 50, recognizes tau proteins in Alzheimer's disease brain.
    Nukina N; Kosik KS; Selkoe DJ
    Neurosci Lett; 1988 May; 87(3):240-6. PubMed ID: 3132653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.
    Slachevsky A; Guzmán-Martínez L; Delgado C; Reyes P; Farías GA; Muñoz-Neira C; Bravo E; Farías M; Flores P; Garrido C; Becker JT; López OL; Maccioni RB
    J Alzheimers Dis; 2017; 55(4):1595-1603. PubMed ID: 27911301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome.
    Tatebe H; Kasai T; Ohmichi T; Kishi Y; Kakeya T; Waragai M; Kondo M; Allsop D; Tokuda T
    Mol Neurodegener; 2017 Sep; 12(1):63. PubMed ID: 28866979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
    Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    Williams SM; Schulz P; Rosenberry TL; Caselli RJ; Sierks MR
    J Alzheimers Dis; 2017; 58(1):23-35. PubMed ID: 28372328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
    Startin CM; Ashton NJ; Hamburg S; Hithersay R; Wiseman FK; Mok KY; Hardy J; Lleó A; Lovestone S; Parnetti L; Zetterberg H; Hye A; ; Strydom A
    Alzheimers Res Ther; 2019 Mar; 11(1):26. PubMed ID: 30902060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer's disease: a systematic review and meta-analysis.
    Ding X; Zhang S; Jiang L; Wang L; Li T; Lei P
    Transl Neurodegener; 2021 Mar; 10(1):10. PubMed ID: 33712071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease.
    Yu ZY; Li WW; Yang HM; Mañucat-Tan NB; Wang J; Wang YR; Sun BL; Hu ZC; Zhang LL; Tan L; Deng J; Liu YH
    Neurotox Res; 2020 Apr; 37(4):1029-1035. PubMed ID: 32026360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease.
    Jicha GA; Berenfeld B; Davies P
    J Neurosci Res; 1999 Mar; 55(6):713-23. PubMed ID: 10220112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease.
    Mengel D; Janelidze S; Glynn RJ; Liu W; Hansson O; Walsh DM
    Ann Neurol; 2020 Nov; 88(5):878-892. PubMed ID: 32829532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent.
    Kim H; Lee JU; Kim S; Song S; Sim SJ
    ACS Sens; 2019 Mar; 4(3):595-602. PubMed ID: 30747516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease.
    Shi Y; Gu L; Wang Q; Gao L; Zhu J; Lu X; Zhou F; Zhu D; Zhang H; Xie C; Zhang Z
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):664-670. PubMed ID: 31336382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    Yang CC; Chiu MJ; Chen TF; Chang HL; Liu BH; Yang SY
    J Alzheimers Dis; 2018; 61(4):1323-1332. PubMed ID: 29376870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants.
    Venkataraman L; He P; Schulz P; Sierks MR
    Neurobiol Aging; 2020 Oct; 94():7-14. PubMed ID: 32497877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
    Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.